Metagenomi Inc. Common St... (MGX)
NASDAQ: MGX
· Real-Time Price · USD
1.92
0.06 (3.23%)
At close: Aug 18, 2025, 2:57 PM
Metagenomi Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Revenue | 33.77M | 45.26M | 52.3M | 55.08M | 55.93M | 47.26M | 44.76M | 37.95M | 30.5M | 22.51M | 17.2M | 11.61M | 6.69M | 3.35M |
Cost of Revenue | n/a | n/a | 1.27M | 2.47M | -15.66M | -14.65M | 4.21M | 3.73M | 22.35M | 29.77M | 18.07M | 17.35M | 16.86M | 8.43M |
Gross Profit | 25.25M | 45.26M | 52.3M | 55.08M | 74.06M | 64.38M | 41.75M | 34.23M | 8.15M | -7.26M | -866K | -5.74M | -10.16M | -5.08M |
Operating Income | -91.81M | -87.69M | -88.9M | -88.47M | -88.49M | -89.59M | -78.49M | -74.06M | -62.54M | -53.58M | -44.64M | -28.87M | -18M | -9M |
Interest Income | 12.18M | 13.68M | 14.72M | 15.16M | 15.41M | 15.4M | 15.47M | 13.77M | 10.98M | 7.01M | 3.01M | 1.08M | n/a | n/a |
Pretax Income | -90.29M | -83.36M | -83.57M | -75.53M | -73.27M | -71.44M | -60.23M | -57.44M | -48.58M | -46.21M | -41.02M | -27.24M | -17.49M | -8.75M |
Net Income | -87.12M | -77.95M | -78.06M | -73.95M | -75M | -77.27M | -68.25M | -63.59M | -54.15M | -50.43M | -43.59M | -28.97M | -18.59M | -9.29M |
Selling & General & Admin | 28.51M | 30.07M | 32.02M | 32.78M | 33.06M | 31.13M | 28.84M | 26.59M | 22.74M | 20.04M | 17.49M | 11.9M | 7.83M | 3.92M |
Research & Development | 97.07M | 102.88M | 109.18M | 110.77M | 111.35M | 105.71M | 94.4M | 84.7M | 69.09M | 54.84M | 43.14M | 28.08M | 16.86M | 8.43M |
Other Expenses | n/a | n/a | n/a | -1.2M | -2.35M | -2.34M | -2.34M | -1.14M | 15K | -8.43M | -16.86M | -16.86M | -16.86M | -8.43M |
Operating Expenses | 125.58M | 132.95M | 141.2M | 142.35M | 142.06M | 134.49M | 120.89M | 110.14M | 91.83M | 66.45M | 43.77M | 23.13M | 7.83M | 3.92M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -719K | -1.21M | -1.21M | -1.21M | -492K | n/a | n/a |
Cost & Expenses | 96.08M | 132.95M | 141.2M | 143.55M | 144.41M | 136.84M | 123.25M | 112.01M | 93.05M | 76.09M | 61.84M | 40.48M | 24.69M | 12.34M |
Income Tax Expense | -3.26M | -5.42M | -5.51M | -1.58M | 1.73M | 5.83M | 8.03M | 6.15M | 5.57M | 4.22M | 2.57M | 1.72M | 1.09M | 546K |
Shares Outstanding (Basic) | 37.16M | 37.02M | 37.09M | 36.77M | 37.46M | 37.47M | 37.47M | 37.47M | 37.47M | 29.96M | 37.47M | 37.47M | 5.93M | 5.93M |
Shares Outstanding (Diluted) | 37.16M | 37.02M | 37.09M | 36.77M | 37.46M | 37.47M | 37.47M | 37.47M | 37.47M | 29.96M | 37.47M | 37.47M | 5.93M | 5.93M |
EPS (Basic) | -2.36 | -2.11 | -2.1 | -1.98 | -2 | -2.06 | -1.93 | -1.81 | -1.55 | -2.78 | -3.81 | -3.42 | -3.14 | -1.57 |
EPS (Diluted) | -2.36 | -2.11 | -2.1 | -1.98 | -2 | -2.06 | -1.93 | -1.81 | -1.55 | -2.78 | -3.81 | -3.42 | -3.14 | -1.57 |
EBITDA | -87.63M | -82.2M | -83.49M | -79.7M | -76.14M | -77.54M | -66.88M | -64.57M | -56.37M | -48.15M | -39.8M | -26.73M | -17.48M | -8.74M |
EBIT | -70.83M | -87.69M | -88.9M | -84.85M | -81.08M | -82.18M | -71.08M | -68.3M | -59.43M | -50.47M | -41.53M | -27.75M | -18M | -9M |
Depreciation & Amortization | 4.18M | 5.49M | 5.41M | 5.15M | 4.94M | 4.64M | 4.21M | 3.73M | 3.06M | 2.31M | 1.73M | 1.01M | 522K | 261K |